We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$56.7B
AUM Growth
+$8.88B
(+19%)
Cap. Flow
+$7.92B
Cap. Flow
% of AUM
13.98%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
2,107
New
102
Increased
1,467
Reduced
463
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$779M |
| 2 |
Apple
AAPL
|
+$539M |
| 3 |
Microsoft
MSFT
|
+$522M |
| 4 |
Meta Platforms (Facebook)
META
|
+$487M |
| 5 |
Tesla
TSLA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$189M |
| 2 |
C.H. Robinson
CHRW
|
+$55.4M |
| 3 |
Fortinet
FTNT
|
+$55M |
| 4 |
AbbVie
ABBV
|
+$35.7M |
| 5 |
NextEra Energy
NEE
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Communication Services | 10.74% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Industrials | 8.58% |
| 5 | Consumer Staples | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPP
1651
Rapport Therapeutics
RAPP
$1.96B
| $222K | ﹤0.01% |
+7,308
| New | +$202K |
|
1652
Worthington Steel
WS
$1.83B
| $221K | ﹤0.01% |
+6,384
| New | +$210K |
|
1653
H&R Block
HRB
$5.58B
| $221K | ﹤0.01% |
5,070
-624
| -11% | -$29.2K |
|
1654
Bio-Rad Laboratories Class A
BIO
$8.71B
| $221K | ﹤0.01% |
729
-48
| -6% | -$15K |
|
1655
Winmark
WINA
$1.2B
| $221K | ﹤0.01% |
545
+35
| +7% | +$15K |
|
1656
Hamilton Lane
HLNE
$4.91B
| $220K | ﹤0.01% |
1,641
-80
| -5% | -$10.1K |
|
1657
SLM Corp
SLM
$4.89B
| $220K | ﹤0.01% |
8,143
-725
| -8% | -$19.9K |
|
1658
Pegasystems
PEGA
$5.02B
| $219K | ﹤0.01% |
3,675
-255
| -6% | -$14.9K |
|
|
VRE
1659
DELISTED
Veris Residential
VRE
| $219K | ﹤0.01% |
14,748
-171
| -1% | -$2.53K |
|
|
CSR
1660
Centerspace
CSR
$921M
| $219K | ﹤0.01% |
+3,285
| New | +$206K |
|
1661
Surgery Partners
SGRY
$2.01B
| $218K | ﹤0.01% |
14,135
+909
| +7% | +$16.7K |
|
1662
Enact Holdings
ACT
$6.61B
| $218K | ﹤0.01% |
5,492
+28
| +0.5% | +$1.05K |
|
1663
Stagwell
STGW
$2.07B
| $218K | ﹤0.01% |
44,513
-8,977
| -17% | -$46.7K |
|
1664
Expro Ltd
XPRO
$1.79B
| $218K | ﹤0.01% |
16,294
-1,365
| -8% | -$18.4K |
|
1665
TETRA Technologies
TTI
$1.14B
| $217K | ﹤0.01% |
23,179
+1,452
| +7% | +$11.2K |
|
|
BBNX
1666
Beta Bionics
BBNX
$577M
| $217K | ﹤0.01% |
+7,115
| New | +$190K |
|
1667
Vontier
VNT
$4.52B
| $216K | ﹤0.01% |
5,819
-420
| -7% | -$16.1K |
|
1668
Harmonic Inc
HLIT
$1.25B
| $216K | ﹤0.01% |
21,870
+653
| +3% | +$6.58K |
|
1669
Dropbox
DBX
$7.6B
| $216K | ﹤0.01% |
7,778
-794
| -9% | -$23.1K |
|
1670
Vital Farms
VITL
$545M
| $216K | ﹤0.01% |
6,764
+841
| +14% | +$29.6K |
|
1671
Oaktree Specialty Lending
OCSL
$1.02B
| $216K | ﹤0.01% |
16,925
-998
| -6% | -$13.3K |
|
1672
Winnebago Industries
WGO
$856M
| $216K | ﹤0.01% |
+5,319
| New | +$194K |
|
1673
Gentherm
THRM
$1.25B
| $215K | ﹤0.01% |
+5,923
| New | +$213K |
|
1674
Vornado Realty Trust
VNO
$7.41B
| $215K | ﹤0.01% |
6,470
-395
| -6% | -$14.4K |
|
1675
Intellia Therapeutics
NTLA
$1.49B
| $215K | ﹤0.01% |
23,914
+3,111
| +15% | +$42.8K |
|
Similar funds
ProShare Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, ProShare Advisors held 2,107 positions worth $56.7B, up 19% from $47.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
ProShare Advisors deployed $7.92B of net new capital in Q4 2025, opening 102 new positions and adding to 1,467 existing holdings. Its largest new stake was CRH: 131,018 shares worth $16.4M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $189M trimmed.
- ProShare Advisors's largest Q4 2025 buy was CRH: 131,018 shares worth $16.4M.
- ProShare Advisors added most to NVIDIA in Q4 2025, an estimated $779M increase.
- ProShare Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $189M.
- ProShare Advisors fully exited Perrigo in Q4 2025, selling an estimated $27.6M.
- ProShare Advisors's ten largest holdings make up 34% of its $56.7B portfolio in Q4 2025.
- ProShare Advisors opened 102 new positions and closed 73 in Q4 2025.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $56.7B.
Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.